Novo Holdings A/S 13D and 13G filings for Hemab Therapeutics Holdings, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 5:05 pm Purchase | 2026-06-30 | 13G | HEMAB THERAPEUTICS HLDGS INC C COAG | Novo Holdings A/S | 4,180,550 9.000% | 4,180,550 (New Position) | Filing |